Cited by 434Inflammation biomarkers and pathwaysImmune Response and InflammationNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

TREM and TREM-like receptors in inflammation and disease

Open access
Ford, Jill W, McVicar, Daniel W·2009·Current Opinion in Immunology

Abstract

Since the discovery of triggering receptor expressed on myeloid cells (TREM)-1 in 2000, evidence documenting the profound ability of the TREM and TREM-like receptors to regulate inflammation has rapidly accumulated. Monocytes, macrophages, myeloid dendritic cells, plasmacytoid dendritic cells, neutrophils, microglia, osteoclasts, and platelets all express at least one member of the TREM family, underscoring the importance of these proteins in the regulation of innate resistance. Recent work on the TREM family includes: characterization of a new receptor expressed on plasmacytoid dendritic cells; definition of a key role for TREM in inflammatory bowel disease and multiple sclerosis; an expanded list of diseases associated with the release of soluble forms of TREM proteins; and identification of the first well characterized TREM ligand: B7-H3, a ligand for TREM-like Transcript (TLT)-2. Moreover, analysis of TREM signaling has now identified key regulatory components and defined pathways that may be responsible for the complex functional interactions between the TREM and toll-like receptors. In addition, there is expanding evidence of a role for TREM in the regulation of integrin function via Plexin-A1. Together these new findings define the TREM and TREM-like receptors as pluripotent modifiers of disease through the integration of inflammatory signals with those associated with leukocyte adhesion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.coi.2009.01.009

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Humans with TREM2 deficiency develop Nasu-Hakola syndrome, characterised by dementia and bone cysts.

    “Humans with TREM2 deficiency develop the Nasu-Hakola syndrome, characterised by dementia and bone cysts [106]”
  • PLCγ2 belongs to the same interaction network as TREM2 and may be directly involved in TREM2 signaling.

    “PLCγ2 belongs to the same interaction network as TREM2 [6] and may be directly involved in its signaling pathway [15, 16].”

    From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [15]

    The citation to this paper is attached to the suggestion that PLCγ2 may be involved in TREM2 signaling; the interaction-network statement has a separate citation. The TREM Signaling section describes TREM2 signaling through DAP12 and NTAL/LAB, but does not mention PLCγ2. Searches for “PLCγ2” and “phospholipase C gamma 2” found no passage connecting it to TREM2. (LLM, conf=0.73)

    Experimental — accuracy not yet measured
  • DAP12 recruits the kinase Syk, which activates downstream mediators including PLC-gamma, PI-3K, and ERK.

    “DAP12 recruits the protein tyrosine kinase Syk, which activates multiple downstream signaling mediators, including PLC-γ, PI-3K, and ERK (111, 112).”
  • TREM2 is a transmembrane glycoprotein expressed in myeloid cells that transmits intracellular signals through the adapters DAP12 and DAP10.

    “TREM2 is transmembrane glycoprotein expressed in myeloid cells that transmits intracellular signals through two associated transmembrane adapters, DAP12 (also known as Tyrobp) and DAP10 (Hcst) (26, 111, 112).”
  • The BAC transgene design deletes essential exons in three other TREM-like genes, which have important innate immunity functions and may play distinct roles in AD.

    “An important aspect of our BAC transgene design is the deletion of essential exons in three other TREM-like genes on the BAC, which are known to have important innate immunity function (Colonna, 2003; Ford and McVicar, 2009), and may play distinct roles in AD (Carrasquillo et al., 2017).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Ford, J. W., & McVicar, D. W.
Affiliations
National Cancer Institute (US)
Corresponding author
McVicar, Daniel W
Venue
Current Opinion in Immunology
Publisher
Elsevier BV
Published
2009-02
Volume
21
Issue
1
Pages
38-46
ISSN
0952-7915 (ISSN-L)
OpenAlex
W2019558661
Cited by
434
References
60
Citations by year
2026: 9 · 2025: 20 · 2024: 14 · 2023: 21 · 2022: 27 · 2021: 30 · 2020: 26 · 2019: 18 · 2018: 28 · 2017: 30 · 2016: 45 · 2015: 27 · 2014: 31 · 2013: 39 · 2012: 22
FWCI
1.78
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (Z99 CA999999)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
TREM-1, TREM2, B7-H3, innate immunity, inflammation, inflammatory bowel disease, multiple sclerosis, plasmacytoid dendritic cells, monocytes, macrophages, microglia, neutrophils, osteoclasts, platelets, Toll-like receptors, PLXNA1, integrin function, leukocyte adhesion
MeSH terms
Triggering Receptor Expressed on Myeloid Cells-1, Animals, Autoimmune Diseases, Bacterial Infections, Cell Adhesion, Dendritic Cells, Gene Expression Regulation, Humans, Inflammation, Membrane Glycoproteins, Osteogenesis, Receptors, Immunologic, Signal Transduction, Antigens, CD, Receptor Cross-Talk, Feedback, Physiological, B7 Antigens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review